HLS THERAPEUTICS INC (HLS.CA) Stock Income Statement
Canada - TSX:HLS - CA40390B1094 - Common Stock
5.59 CAD
-0.13 (-2.27%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 56.42M | 56.62M | 63.07M | 61.50M | 60.00M | |||
| Cost Of Goods | 9.82M | 9.00M | 7.62M | 5.00M | 4.00M | |||
| Gross Profit | 46.60M | 47.62M | 55.45M | 56.50M | 56.00M | |||
| Operating Expenses | 53.07M | 56.82M | 67.26M | 70.00M | 62.20M | |||
| Selling, General, and Administrative Expenses | 29.98M | 32.59M | 33.86M | 35.60M | 32.10M | |||
| Operating Income | -6.47M | -9.19M | -11.81M | -13.50M | -6.20M | |||
| Interest Income/Expense | -8.33M | -9.77M | -9.78M | -5.00M | -5.40M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Non Recurring Items | N/A | 3.38M | -6.22M | -5.20M | -200.00K | |||
| Income Before Taxes | -14.80M | -15.58M | -27.80M | -23.70M | -11.80M | |||
| Income Tax | 245.00K | 4.07M | -272.00K | -100.00K | 1.30M | |||
| Net Income | -15.04M | -19.66M | -27.53M | -23.60M | -13.10M | |||
| EBITDA | 15.31M | 13.52M | 20.13M | 20.90M | 24.06M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.47 | -0.62 | -0.85 | -0.73 | -0.41 | |||
| Non GAAP EPS | -0.48 | -0.62 | -0.85 | -0.59 | -0.41 | |||
| Statistics | ||||||||
| Gross Profit Margin | 82.59% | 84.11% | 87.91% | 91.87% | 93.33% | |||
| Profit Margin | -26.66% | -34.71% | -43.65% | -38.37% | -21.83% | |||
| Operating Profit Margin | -11.47% | -16.24% | -18.72% | -21.95% | -10.33% | |||
All data in USD